30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Petlife Pharmaceuticals Inc (PTLF)

Track

Stock chart
Ticker: PTLF Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Campbell Vyvyan
1 purchase — total 1,225,185,000 USD
Buy 28 Feb 2018
Value US$4,278,814.46 | Price 458.63 | Shares 78,929
Buy 23 Feb 2017
Value US$934,445.86 | Price 276.30 | Shares 35,023
Buy 15 May 2016
Value US$273,087.50 | Price 1.25 | Shares 218,470
Buy 12 Feb 2016
Value US$160,000.00 | Price 0.64 | Shares 250,000
Buy 12 Feb 2016
Value US$248,400.00 | Price 0.46 | Shares 540,000
Buy 12 Feb 2016
Value US$160,000.00 | Price 0.64 | Shares 250,000
Buy 29 Dec 2015
Value US$25,000.00 | Price 0.25 | Shares 100,000
Buy 9 Nov 2015
Value US$25,000.00 | Price 0.25 | Shares 100,000
Buy 30 May 2015
Value US$37,657.50 | Price 0.75 | Shares 50,210
Sale 13 Dec 2007
Value US$5,200.00 | Price 0.00 | Shares 13,000,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2018-03-20 2018-02-28 B Purchase Campbell Vyvyan
78,929 -45.5%
458.63
US$4,278,814 		78,929 -45.5% 458.63 US$4,278,814
2017-03-24 2017-02-23 B Purchase Campbell Vyvyan Large shareholder
35,023 -38.5%
276.30
US$934,446 		35,023 -38.5% 276.30 US$934,446
2017-03-24 2016-05-15 B Purchase Campbell Vyvyan Large shareholder
68,037 +13.9%
445.15
US$2,916,489 		68,037 +13.9% 445.15 US$2,916,489
2017-03-27 2016-02-12 B Purchase Salvagno Ralph T

CEO

Executive Director Large shareholder
250,000 +28.1%
0.64
US$160,000 		250,000 +28.1% 0.64 US$160,000
2017-03-27 2016-02-12 B Purchase Salvagno Ralph T

CEO

Executive Director Large shareholder
540,000 +154.3%
0.46
US$248,400 		540,000 +154.3% 0.46 US$248,400
2017-03-27 2016-02-12 B Purchase Salvagno Ralph T

CEO

Executive Director Large shareholder
250,000 +250.0%
0.64
US$160,000 		250,000 +250.0% 0.64 US$160,000
2017-03-27 2015-12-29 B Purchase Salvagno Ralph T

CEO

Executive Director Large shareholder
100,000 +inf%
0.25
US$25,000 		100,000 +inf% 0.25 US$25,000
2017-03-24 2015-11-09 B Purchase Campbell Vyvyan Large shareholder
100,000 +199.2%
0.25
US$25,000 		100,000 +199.2% 0.25 US$25,000
2017-03-24 2015-05-30 B Purchase Campbell Vyvyan Large shareholder
50,210 +inf%
0.75
US$37,658 		50,210 +inf% 0.75 US$37,658
2007-12-18 2007-12-13 S Sale WHITE CURT C

Former 10%/Officer/Director
13,000,000 -94.5%
0.00
US$5,200 		13,000,000 -94.5% 0.00 US$5,200
Explore more

More insider trading research around Petlife Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America